DJSG
TEVA icon

D.J. St. Germain’s Teva Pharmaceuticals TEVA Stock Holding History

D.J. St. Germain’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37
Closed -$522 – 838
2024
Q1 		$522 Hold
37
– – ﹤0.01% 739
2023
Q4 		$386 Hold
37
– – ﹤0.01% 748
2023
Q3 		$377 Hold
37
– – ﹤0.01% 721
2023
Q2 		$279 Buy
+37
New +$300 ﹤0.01% 699
2017
Q4 		– Sell
-66,727
Closed -$1.17M – 153
2017
Q3 		$1.17M Sell
66,727
-1,181
-2% -$26.6K 0.15% 75
2017
Q2 		$2.26M Sell
67,908
-1,275
-2% -$39.5K 0.3% 61
2017
Q1 		$2.22M Buy
69,183
+295
+0.4% +$10.1K 0.31% 61
2016
Q4 		$2.5M Sell
68,888
-61,826
-47% -$2.47M 0.34% 62
2016
Q3 		$6.01M Sell
130,714
-3,129
-2% -$163K 0.84% 40
2016
Q2 		$6.72M Sell
133,843
-2,236
-2% -$119K 0.94% 37
2016
Q1 		$7.28M Sell
136,079
-2,695
-2% -$158K 1.04% 37
2015
Q4 		$9.11M Sell
138,774
-1,043
-0.7% -$64.5K 1.37% 32
2015
Q3 		$7.89M Sell
139,817
-2,082
-1% -$135K 1.32% 32
2015
Q2 		$8.39M Sell
141,899
-1,129
-0.8% -$69.6K 1.27% 35
2015
Q1 		$8.91M Sell
143,028
-1,245
-0.9% -$72.4K 1.29% 33
2014
Q4 		$8.3M Sell
144,273
-2,825
-2% -$157K 1.21% 34
2014
Q3 		$7.91M Sell
147,098
-987
-0.7% -$52.3K 1.19% 35
2014
Q2 		$7.76M Sell
148,085
-4,353
-3% -$222K 1.14% 35
2014
Q1 		$8.05M Sell
152,438
-11,115
-7% -$514K 1.23% 34
2013
Q4 		$6.55M Sell
163,553
-4,705
-3% -$185K 0.96% 37
2013
Q3 		$6.36M Sell
168,258
-4,464
-3% -$174K 1.02% 36
2013
Q2 		$6.77M Buy
+172,722
New +$6.73M 1.12% 37

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.J. St. Germain's TEVA Position: Q2 2024 in Review

D.J. St. Germain sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 37 shares — an estimated $522 sold.

D.J. St. Germain first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $9.11M in Q4 2015. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • D.J. St. Germain reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • D.J. St. Germain sold 37 Teva Pharmaceuticals shares in Q2 2024, an estimated $522.
  • D.J. St. Germain first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • D.J. St. Germain's Teva Pharmaceuticals position peaked at $9.11M in Q4 2015.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on D.J. St. Germain's 13F filing for Q2 2024, filed 8 Jul 2024.